Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: Docetaxel Cyclophosphamide|DRUG: Cyclophosphamide Fluorouracil Epirubicin Docetaxel|DRUG: Epirubicin Cyclophosphamide Paclitaxel
Sponsor: Fudan University
Collaborators: Chinese Anti-Cancer Association